Market revenue in 2023 | USD 1,362.4 million |
Market revenue in 2030 | USD 2,307.0 million |
Growth rate | 7.8% (CAGR from 2023 to 2030) |
Largest segment | General |
Fastest growing segment | Support |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | General, Analytical, Clinical, Support, Specialty |
Key market players worldwide | Sartorius AG, Bio-Rad Laboratories Inc, FUJIFILM Holdings Corp, Thermo Fisher Scientific Inc, Agilent Technologies Inc |
General was the largest segment with a revenue share of 27.08% in 2023. Horizon Databook has segmented the China laboratory equipment market based on general, analytical, clinical, support, specialty covering the revenue growth of each sub-segment from 2018 to 2030.
According to an article published in Live Science, the Chinese government aims to build 5 to 7 high-containment labs in the country by 2025. In May 2020, Chengdu Institute of Biological Products Co, Ltd. obtained registration for 15 secondary biosafety laboratories. The development of new labs is anticipated to increase the demand for lab equipment, especially biosafety cabinets.
China is the forerunner in global COVID-19-related clinical trials. According to WHO data, as of July 2020, there were more than 820 COVID-19 clinical trials registered in the country. Moreover, nearly 40% of the global clinical trials related COVID-19 vaccine are being conducted in China.
The Chinese government is providing funds for trials and has also fast-tracked projects related to vaccine development. Such supportive government initiatives and the large number of clinical trials are anticipated to facilitate market growth, due to high laboratory work associated with trials and vaccine development.
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account